MEDICAL PROPERTIES TRUST INC (MPW) Fundamental Analysis & Valuation

NYSE:MPW • US58463J3041

Current stock price

5.02 USD
-0.03 (-0.59%)
At close:
5.03 USD
+0.01 (+0.2%)
After Hours:

This MPW fundamental analysis includes valuation metrics, fair value assessment, financial health analysis, profitability trends, growth metrics and dividend sustainability analysis.

4

1. MPW Profitability Analysis

1.1 Basic Checks

  • MPW had negative earnings in the past year.
  • MPW had a positive operating cash flow in the past year.
  • The reported net income has been mixed in the past 5 years: MPW reported negative net income in multiple years.
  • MPW had a positive operating cash flow in each of the past 5 years.
MPW Yearly Net Income VS EBIT VS OCF VS FCFMPW Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 1B -1B -2B -3B -4B

1.2 Ratios

  • MPW has a Return On Assets of -4.74%. This is amonst the worse of the industry: MPW underperforms 81.45% of its industry peers.
  • MPW has a worse Return On Equity (-15.19%) than 77.42% of its industry peers.
  • MPW has a Return On Invested Capital (2.76%) which is comparable to the rest of the industry.
  • MPW had an Average Return On Invested Capital over the past 3 years of 2.26%. This is in line with the industry average of 3.11%.
  • The last Return On Invested Capital (2.76%) for MPW is above the 3 year average (2.26%), which is a sign of increasing profitability.
Industry RankSector Rank
ROA -4.74%
ROE -15.19%
ROIC 2.76%
ROA(3y)-5.11%
ROA(5y)-1.92%
ROE(3y)-15.57%
ROE(5y)-6.62%
ROIC(3y)2.26%
ROIC(5y)2.99%
MPW Yearly ROA, ROE, ROICMPW Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 20 -20 -40

1.3 Margins

  • MPW has a Operating Margin of 53.48%. This is amongst the best in the industry. MPW outperforms 95.97% of its industry peers.
  • MPW's Operating Margin has declined in the last couple of years.
  • MPW's Gross Margin of 96.07% is amongst the best of the industry. MPW outperforms 97.58% of its industry peers.
  • MPW's Gross Margin has been stable in the last couple of years.
Industry RankSector Rank
OM 53.48%
PM (TTM) N/A
GM 96.07%
OM growth 3Y-16.71%
OM growth 5Y-10.61%
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-0.03%
GM growth 5Y-0.02%
MPW Yearly Profit, Operating, Gross MarginsMPW Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 100 -100 -200

More info and screens

ROAROEROICOperating and Profit MarginShow most profitable peers

2

2. MPW Health Analysis

2.1 Basic Checks

  • MPW has a Return on Invested Capital (ROIC), which is below the Cost of Capital (WACC), which means it is destroying value.
  • The number of shares outstanding for MPW has been increased compared to 1 year ago.
  • The number of shares outstanding for MPW has been increased compared to 5 years ago.
  • Compared to 1 year ago, MPW has a worse debt to assets ratio.
MPW Yearly Shares OutstandingMPW Yearly Shares OutstandingYearly Shares Outstanding 2016 2017 2018 2019 2020 2021 2022 2023 2024 200M 400M 600M
MPW Yearly Total Debt VS Total AssetsMPW Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2016 2017 2018 2019 2020 2021 2022 2023 2024 5B 10B 15B 20B

2.2 Solvency

  • MPW has an Altman-Z score of 0.02. This is a bad value and indicates that MPW is not financially healthy and even has some risk of bankruptcy.
  • With a Altman-Z score value of 0.02, MPW is not doing good in the industry: 75.00% of the companies in the same industry are doing better.
  • A Debt/Equity ratio of 2.06 is on the high side and indicates that MPW has dependencies on debt financing.
  • MPW's Debt to Equity ratio of 2.06 is on the low side compared to the rest of the industry. MPW is outperformed by 70.97% of its industry peers.
Industry RankSector Rank
Debt/Equity 2.06
Debt/FCF N/A
Altman-Z 0.02
ROIC/WACC0.45
WACC6.13%
MPW Yearly LT Debt VS Equity VS FCFMPW Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 5B 10B

2.3 Liquidity

  • MPW has a Current Ratio of 2.00. This is a normal value and indicates that MPW is financially healthy and should not expect problems in meeting its short term obligations.
  • Looking at the Current ratio, with a value of 2.00, MPW belongs to the top of the industry, outperforming 82.26% of the companies in the same industry.
  • MPW has a Quick Ratio of 2.00. This is a normal value and indicates that MPW is financially healthy and should not expect problems in meeting its short term obligations.
  • The Quick ratio of MPW (2.00) is better than 82.26% of its industry peers.
Industry RankSector Rank
Current Ratio 2
Quick Ratio 2
MPW Yearly Current Assets VS Current LiabilitesMPW Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2016 2017 2018 2019 2020 2021 2022 2023 2024 500M 1B 1.5B

More info and screens

WACCDebt/EquityHow to determine the health of a companyAltman-Z scoreShow peers with great health

4

3. MPW Growth Analysis

3.1 Past

  • MPW shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 43.50%, which is quite impressive.
  • Looking at the last year, MPW shows a very strong growth in Revenue. The Revenue has grown by 45.56%.
  • MPW shows a small growth in Revenue. Measured over the last years, the Revenue has been growing by 3.11% yearly.
EPS 1Y (TTM)43.5%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%90.3%
Revenue 1Y (TTM)45.56%
Revenue growth 3Y-13.62%
Revenue growth 5Y3.11%
Sales Q2Q%5.18%

3.2 Future

  • The Earnings Per Share is expected to grow by 27.42% on average over the next years. This is a very strong growth
  • MPW is expected to show a small growth in Revenue. In the coming years, the Revenue will grow by 2.08% yearly.
EPS Next Y85.75%
EPS Next 2Y42.83%
EPS Next 3Y27.42%
EPS Next 5YN/A
Revenue Next Year-4.36%
Revenue Next 2Y1.29%
Revenue Next 3Y3.17%
Revenue Next 5Y2.08%

3.3 Evolution

  • The Revenue growth rate is decreasing: in the next years the growth will be less than in the last years.
MPW Yearly Revenue VS EstimatesMPW Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 500M 1B 1.5B
MPW Yearly EPS VS EstimatesMPW Yearly EPS VS EstimatesYearly EPS VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 0 2 -2

More info and screens

Find the best growth stocksShow best growing peers

2

4. MPW Valuation Analysis

4.1 Price/Earnings Ratio

  • The Price/Earnings Ratio is negative for MPW. In the last year negative earnings were reported.
  • With a Price/Forward Earnings ratio of 47.34, MPW can be considered very expensive at the moment.
  • Compared to the rest of the industry, the Price/Forward Earnings ratio of MPW indicates a somewhat cheap valuation: MPW is cheaper than 64.52% of the companies listed in the same industry.
  • MPW is valuated expensively when we compare the Price/Forward Earnings ratio to 24.12, which is the current average of the S&P500 Index.
Industry RankSector Rank
PE N/A
Fwd PE 47.34
MPW Price Earnings VS Forward Price EarningsMPW Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 20 40 60

4.2 Price Multiples

  • MPW's Enterprise Value to EBITDA is on the same level as the industry average.
Industry RankSector Rank
P/FCF N/A
EV/EBITDA 15.92
MPW Per share dataMPW EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 2 4 6

4.3 Compensation for Growth

  • MPW's low PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a rather cheap valuation of the company.
  • MPW's earnings are expected to grow with 27.42% in the coming years. This may justify a more expensive valuation.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y42.83%
EPS Next 3Y27.42%

More info and screens

Price/EarningsPrice/FCFFCF per shareEV/EBITDAPEG RATIOShow best valued peers

5

5. MPW Dividend Analysis

5.1 Amount

  • MPW has a Yearly Dividend Yield of 7.17%, which is a nice return.
  • Compared to an average industry Dividend Yield of 7.30, MPW pays a bit more dividend than its industry peers.
  • MPW's Dividend Yield is rather good when compared to the S&P500 average which is at 1.91.
Industry RankSector Rank
Dividend Yield 7.17%

5.2 History

  • The dividend of MPW decreases each year by -10.38%.
  • MPW has been paying a dividend for at least 10 years, so it has a reliable track record.
Dividend Growth(5Y)-10.38%
Div Incr Years0
Div Non Decr Years0
MPW Yearly Dividends per shareMPW Yearly Dividends per shareYearly Dividends per share 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0.2 0.4 0.6 0.8 1

5.3 Sustainability

  • The earnings of MPW are negative and hence is the payout ratio. MPW will probably not be able to sustain this dividend level.
DP-27.26%
EPS Next 2Y42.83%
EPS Next 3Y27.42%
MPW Yearly Income VS Free CF VS DividendMPW Yearly Income VS Free CF VS DividendYearly Income VS Free CF VS Dividend 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 1B -1B -2B -3B -4B

More info and screens

Find the best dividend stocksShow peers with best dividend

MPW Fundamentals: All Metrics, Ratios and Statistics

MEDICAL PROPERTIES TRUST INC

NYSE:MPW (1/30/2026, 8:07:14 PM)

After market: 5.03 +0.01 (+0.2%)

5.02

-0.03 (-0.59%)

Chartmill FA Rating
GICS SectorReal Estate
GICS IndustryGroupEquity Real Estate Investment Trusts (REITs)
GICS IndustryDiversified REITs
Earnings (Last)10-30
Earnings (Next)02-19
Inst Owners57.85%
Inst Owner Change1.8%
Ins Owners17.26%
Ins Owner Change18.96%
Market Cap3.02B
Revenue(TTM)933.52M
Net Income(TTM)-707.95M
Analysts51.76
Price Target5.27 (4.98%)
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield 7.17%
Yearly Dividend0.54
Dividend Growth(5Y)-10.38%
DP-27.26%
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)1
Avg EPS beat(2)-873.24%
Min EPS beat(2)-1816.17%
Max EPS beat(2)69.68%
EPS beat(4)1
Avg EPS beat(4)-3643.79%
Min EPS beat(4)-11757.5%
Max EPS beat(4)69.68%
EPS beat(8)2
Avg EPS beat(8)-2173.83%
EPS beat(12)2
Avg EPS beat(12)-1482.28%
EPS beat(16)6
Avg EPS beat(16)-1094.33%
Revenue beat(2)2
Avg Revenue beat(2)1.43%
Min Revenue beat(2)0.7%
Max Revenue beat(2)2.15%
Revenue beat(4)3
Avg Revenue beat(4)1.19%
Min Revenue beat(4)-3.58%
Max Revenue beat(4)5.51%
Revenue beat(8)5
Avg Revenue beat(8)0.69%
Revenue beat(12)6
Avg Revenue beat(12)-0.69%
Revenue beat(16)7
Avg Revenue beat(16)-1.26%
PT rev (1m)0.46%
PT rev (3m)6.37%
EPS NQ rev (1m)0%
EPS NQ rev (3m)-25%
EPS NY rev (1m)0%
EPS NY rev (3m)-44.66%
Revenue NQ rev (1m)-0.44%
Revenue NQ rev (3m)0.4%
Revenue NY rev (1m)-0.47%
Revenue NY rev (3m)0.55%
Valuation
Industry RankSector Rank
PE N/A
Fwd PE 47.34
P/S 3.23
P/FCF N/A
P/OCF 20.49
P/B 0.65
P/tB 0.65
EV/EBITDA 15.92
EPS(TTM)-1
EYN/A
EPS(NY)0.11
Fwd EY2.11%
FCF(TTM)-0.07
FCFYN/A
OCF(TTM)0.25
OCFY4.88%
SpS1.55
BVpS7.75
TBVpS7.75
PEG (NY)N/A
PEG (5Y)N/A
Graham NumberN/A
Profitability
Industry RankSector Rank
ROA -4.74%
ROE -15.19%
ROCE 3.49%
ROIC 2.76%
ROICexc 2.84%
ROICexgc 2.95%
OM 53.48%
PM (TTM) N/A
GM 96.07%
FCFM N/A
ROA(3y)-5.11%
ROA(5y)-1.92%
ROE(3y)-15.57%
ROE(5y)-6.62%
ROIC(3y)2.26%
ROIC(5y)2.99%
ROICexc(3y)2.3%
ROICexc(5y)3.06%
ROICexgc(3y)2.37%
ROICexgc(5y)3.14%
ROCE(3y)2.86%
ROCE(5y)3.79%
ROICexgc growth 3Y-18.25%
ROICexgc growth 5Y-8.72%
ROICexc growth 3Y-18.71%
ROICexc growth 5Y-8.92%
OM growth 3Y-16.71%
OM growth 5Y-10.61%
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-0.03%
GM growth 5Y-0.02%
F-Score5
Asset Turnover0.06
Health
Industry RankSector Rank
Debt/Equity 2.06
Debt/FCF N/A
Debt/EBITDA 12.51
Cap/Depr 69.46%
Cap/Sales 20.04%
Interest Coverage 1.08
Cash Conversion 19.18%
Profit Quality N/A
Current Ratio 2
Quick Ratio 2
Altman-Z 0.02
F-Score5
WACC6.13%
ROIC/WACC0.45
Cap/Depr(3y)171.64%
Cap/Depr(5y)740.47%
Cap/Sales(3y)50.73%
Cap/Sales(5y)169.71%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)43.5%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%90.3%
EPS Next Y85.75%
EPS Next 2Y42.83%
EPS Next 3Y27.42%
EPS Next 5YN/A
Revenue 1Y (TTM)45.56%
Revenue growth 3Y-13.62%
Revenue growth 5Y3.11%
Sales Q2Q%5.18%
Revenue Next Year-4.36%
Revenue Next 2Y1.29%
Revenue Next 3Y3.17%
Revenue Next 5Y2.08%
EBIT growth 1Y1889.1%
EBIT growth 3Y-28.05%
EBIT growth 5Y-7.83%
EBIT Next Year118.66%
EBIT Next 3Y36.12%
EBIT Next 5Y20.09%
FCF growth 1Y70.94%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y-73.27%
OCF growth 3Y-32.88%
OCF growth 5Y-13.06%

MEDICAL PROPERTIES TRUST INC / MPW Fundamental Analysis FAQ

What is the fundamental rating for MPW stock?

ChartMill assigns a fundamental rating of 3 / 10 to MPW.


Can you provide the valuation status for MEDICAL PROPERTIES TRUST INC?

ChartMill assigns a valuation rating of 2 / 10 to MEDICAL PROPERTIES TRUST INC (MPW). This can be considered as Overvalued.


Can you provide the profitability details for MEDICAL PROPERTIES TRUST INC?

MEDICAL PROPERTIES TRUST INC (MPW) has a profitability rating of 4 / 10.


Can you provide the financial health for MPW stock?

The financial health rating of MEDICAL PROPERTIES TRUST INC (MPW) is 2 / 10.


What is the expected EPS growth for MEDICAL PROPERTIES TRUST INC (MPW) stock?

The Earnings per Share (EPS) of MEDICAL PROPERTIES TRUST INC (MPW) is expected to grow by 85.75% in the next year.